On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria

被引:24
|
作者
Burghardt, H
Schimz, KL
Müller, M
机构
[1] Univ Munich, Adolf Butenandt Inst Phys Biochem, D-80336 Munich, Germany
[2] Forschungszentrum Julich, Inst Biotechnol, D-52425 Julich, Germany
来源
FEBS LETTERS | 1998年 / 425卷 / 01期
关键词
antibiotic; gram-positive bacterium; oxazolidinone; ribosomal subunit; translation initiation;
D O I
10.1016/S0014-5793(98)00194-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxazolidinones are a promising new class of synthetic antibiotics active against multidrug-resistant Gram-positive bacteria, To elucidate their mode of action, the effect of DuP 721 on individual steps of protein translation was studied. The drug does not interfere with translation initiation at the stage of mRNA binding or formation of 30S pre-initiation complexes. However, it inhibits the puromycin-mediated release of /S-35/formyl-methionine from 70S initiation complexes in a dose-dependent manner. Inhibition involves binding of the oxazolidinone to the large ribosomal subunit and is twice as high with 50S subunits from Gram-positive as with those from Gram-negative bacteria, (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 46 条
  • [1] Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria
    Otsuka, Yasunari
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 182 - 190
  • [2] Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
    George G. Zhanel
    Riley Love
    Heather Adam
    Alyssa Golden
    Sheryl Zelenitsky
    Frank Schweizer
    Bala Gorityala
    Philippe R. S. Lagacé-Wiens
    Ethan Rubinstein
    Andrew Walkty
    Alfred S. Gin
    Matthew Gilmour
    Daryl J. Hoban
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2015, 75 : 253 - 270
  • [3] Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
    Zhu, Xiaoli
    Hong, Anjin
    Sun, Xihuan
    Wang, Weijie
    He, Guanghui
    Luo, Huan
    Wu, Zhenhua
    Xu, Qingyan
    Hu, Zhiyu
    Wu, Xiaobing
    Huang, Donghong
    Li, Li
    Zhao, Xilin
    Deng, Xianming
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [4] Aprosamine Derivatives Active against Multidrug-Resistant Gram- Negative Bacteria
    Otsuka, Yasunari
    Umemura, Eijiro
    Takamiya, Yukimi
    Ishibashi, Teruhisa
    Hayashi, Chigusa
    Yamada, Keiko
    Igarashi, Masayuki
    Shibasaki, Masakatsu
    Takahashi, Yoshiaki
    ACS INFECTIOUS DISEASES, 2023, 9 (04): : 886 - 898
  • [5] The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria
    Rybak, MJ
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 24 - 32
  • [6] Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against gram-positive bacteria
    Liu, Jidong
    He, Baoyuan
    Yu, Aizhen
    Zhou, Weicheng
    CHEMICAL BIOLOGY & DRUG DESIGN, 2007, 69 (04) : 265 - 268
  • [7] Novel agents for the treatment of resistant Gram-positive infections
    Woodford, N
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 117 - 137
  • [8] Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria
    Klobucar, Kristina
    Jardine, Emily
    Farha, Maya A.
    MacKinnon, Marc R.
    Fragis, Meghan
    Nkonge, Brenda
    Bhando, Timsy
    Borrillo, Louis
    Tsai, Caressa N.
    Johnson, Jarrod W.
    Coombes, Brian K.
    Magolan, Jakob
    Brown, Eric D.
    ACS INFECTIOUS DISEASES, 2022, 8 (10): : 2187 - 2197
  • [9] Lipoglycopeptide Antibiotics: Reliable Fighters Against Gram-Positive Pathogens
    Bagheri, Haleh
    Sohrabi, Bahram
    Salarian, Sara
    Bagheri, Bahador
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2018, 13 (06):
  • [10] One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria
    Moraski, Garrett C.
    Thanassi, Jane A.
    Podos, Steven D.
    Pucci, Michael J.
    Miller, Marvin J.
    JOURNAL OF ANTIBIOTICS, 2011, 64 (10) : 667 - 671